(2E)-1-(3,4-dichlorophenyl)-3-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

(4-(3,5-Difluorophenoxy)phenyl)boronic acid, 95.0%, 100mg

Ethyl 7-nitro-1H-indole-2-carboxylate, 95.0%, 1g

4-Fluoro-3-nitrophenylboronic acid, 95.0%, 10g

4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile, 95.0%, 200mg

(4-Amino-2-chloropyrimidin-5-yl)methanol, 95%, 1g

Thorin, pa, 5 g, envase de vidrio

TELATINIB, 95%, 5mg

Polydimethylsiloxanes, trimethylsiloxy terminated cSt 20,000,000, 100g

(E)-3-(1H-Indol-6-yl)acrylic acid, 95%, 1g

trans-2-Hexen-1-ol>95.0%(GC)250g

1-Fluorocyclopropanecarboxylic acid, 95.0%, 25g

2-(1-(((Benzyloxy)carbonyl)amino)cyclohexyl)acetic acid, 95%, 500mg